In summary the study showed that plasma concentrations of HMGB1 and IL-6 assessed at ICU admission could accurately identify COVID-19 patients with a fatal outcome of the disease, with a predictive precision similar to or better than the SOFA or the COVID-GRAM risk scores. The gene discussed is HMGB1; the disease is COVID-19.